News
Oxford, UK - 9 May 2025: OXB (LSE: OXB), a global quality and innovation-led cell and gene therapy CDMO, today announces its ...
Collaboration, equity, and cutting-edge infrastructure converge to transform NSW into a global health research leader.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results